Indeterminate molecular subgroup
Showing 1 - 25 of 6,459
Molecular Markers for Indeterminate Thyroid Nodules
Recruiting
- Thyroid
- Afirma GEC
- +3 more
-
Los Angeles, CaliforniaJonsson Comprehensive Cancer Center at UCLA
May 16, 2022
Brain Tumor, Brain Tumor, Recurrent, Brain Tumor, Refractory Trial in Memphis (Prexasertib, Cyclophosphamide, Gemcitabine)
Active, not recruiting
- Brain Tumor
- +12 more
- Prexasertib
- +4 more
-
Memphis, TennesseeSt. Jude Children's Research Hospital
Oct 20, 2022
Endometrial Adenocarcinoma Trial in Helsinki (Comparison of adjuvant therapies)
Recruiting
- Endometrial Adenocarcinoma
- Comparison of adjuvant therapies
-
Helsinki, FinlandHelsinki University Hospital
Dec 8, 2022
Staging Endometrial caNcer Based on molEcular ClAssification
Recruiting
- Endometrial Cancer
- +2 more
-
Pamplona, Navarra, SpainClinica Universidad de Navarra
Jan 30, 2023
Molecular Profile of Thyroid Nodules
Not yet recruiting
- Thyroid Cancer
- Thyroid Nodule
- Molecular testing
- (no location specified)
Apr 5, 2022
Medulloblastoma Trial in Memphis (procedure, drug, radiation)
Recruiting
- Medulloblastoma
- Surgical resection
- +11 more
-
Memphis, TennesseeSt. Jude Children's Research Hospital
Sep 16, 2022
stratification of High-risk Intestinal Metaplasia (GCEP2 Study)
Recruiting
- Stomach Neoplasm
- Blood Collection, processing and analyses
- +2 more
-
Stanford, California
- +7 more
Mar 13, 2023
MyLeukoMAP™ Genomic Survival Prediction Assay Pivotal Clinical
Recruiting
- Heart Failure
- Observational
-
Kansas City, MissouriSaint Luke's Hospital of Kansas City
Jul 13, 2022
Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage IA Breast Cancer AJCC v8, Anatomic Stage IB Breast Cancer AJCC v8 Trial
Active, not recruiting
- Anatomic Stage I Breast Cancer AJCC v8
- +22 more
- Biopsy
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Feb 25, 2022
Thyroid Cancer Trial in Toulouse, Montpellier (Signature of 10 microRNA for patients with bethesda classification 3, 4 or 5)
Recruiting
- Thyroid Cancer
- Signature of microRNA for patients with bethesda classification 3, 4 or 5
-
Toulouse, Haute-Garonne, France
- +1 more
Jan 13, 2023
Clear Cell Renal Cell Carcinoma Trial in Worldwide (89Zr-girentuximab)
Recruiting
- Clear Cell Renal Cell Carcinoma
- 89Zr-girentuximab
-
Duarte, California
- +29 more
Aug 4, 2021
Myeloproliferative Tumor, Secondary Leukemia Trial (Multiomic characterization, In vitro drug screening)
Not yet recruiting
- Myeloproliferative Neoplasm
- Secondary Leukemia
- Multiomic characterization
- In vitro drug screening
- (no location specified)
Aug 28, 2023
Autoimmune Cytopenias Including Autoimmune Hemolytic Anemia,
Recruiting
- Autoimmune Hemolytic Anemia
- +5 more
- cytokine essays
- +6 more
-
Milano, ItalyFondazione Irccs Ca' Granda Ospedale Maggiore Policlinico
Jul 3, 2023
Surveillance of Indeterminate Pulmonary Nodules
Completed
- Lung Cancer
- Biosample and Imaging Collection
-
Los Angeles, California
- +14 more
Feb 28, 2022
Next Generation LAM Assays and Molecular Diagnostics for
Not yet recruiting
- Tuberculosis
- (no location specified)
Aug 24, 2023
Bioneer Accupower Q-RFIA PCR Kit Clinical Evaluation
Recruiting
- Tuberculosis, Multidrug-Resistant
-
Nairobi, Kenya
- +2 more
Mar 16, 2022
Lung Cancer, Video-assisted Thoracic Surgery, EGFR Trial in Torino (Cetuximab-IRDye800)
Not yet recruiting
- Lung Cancer
- +3 more
-
Torino, TO, ItalyAzienda Ospedaliera Universitaria Città della Salute e della Sci
Oct 23, 2023
Colorectal Cancers With Microsatellite Instability
Active, not recruiting
- Colorectal Cancer
- Microsatellite Instability
-
Poitiers, Vienne, France
- +13 more
Aug 19, 2022
Gut Microbiome, Mood Disorders Trial in Beirut (Cerebiome, Placebo)
Not yet recruiting
- Gut Microbiome
- Mood Disorders
- Cerebiome
- Placebo
-
Beirut, LebanonSaint-Joseph University
Dec 2, 2022
Choroidal Melanoma, Indeterminate Lesions, Uveal Melanoma Trial in United States (Belzupacap Sarotalocan, Suprachoroidal
Recruiting
- Choroidal Melanoma
- +3 more
- Belzupacap Sarotalocan
- +5 more
-
Birmingham, Alabama
- +32 more
Aug 23, 2023
Concordance of Molecular Classification Based on Fine Needle
Not yet recruiting
- Papillary Thyroid Cancer
-
Calgary, Alberta, CanadaFoothills Medical Centre
Nov 17, 2023
Performances of DendrisCHIP®OA in Bone and Joint Infections
Not yet recruiting
- Bone Infection
- +2 more
-
Boulogne-Billancourt, FranceLaboratory of microbiology, Ambroise Paré hospital - APHP
Nov 13, 2023
Indeterminate Thyroid Nodules Across Different World Regions
Recruiting
- Indeterminate Thyroid Nodules
- Thyroidectomy
-
Cagliari, CA, ItalyAOU Cagliari
May 1, 2023
Sepsis, Molecular Diagnosis Trial in Tarragona (Septicyte Rapid ®, FilmArray® blood culture identification (BCID2®))
Recruiting
- Sepsis
- Molecular Diagnosis
- Septicyte Rapid ®
- FilmArray® blood culture identification (BCID2®)
-
Tarragona, SpainAlejandro Rodriguez
Apr 17, 2023